(NASDAQ: XOMA) Xoma Royalty's forecast annual revenue growth rate of 36.91% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 35.63%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.33%.
Xoma Royalty's revenue in 2026 is $52,149,000.On average, 7 Wall Street analysts forecast XOMA's revenue for 2026 to be $775,760,379, with the lowest XOMA revenue forecast at $602,866,500, and the highest XOMA revenue forecast at $1,150,526,492. On average, 4 Wall Street analysts forecast XOMA's revenue for 2027 to be $823,835,401, with the lowest XOMA revenue forecast at $765,152,443, and the highest XOMA revenue forecast at $876,315,515.
In 2028, XOMA is forecast to generate $1,719,414,262 in revenue, with the lowest revenue forecast at $893,733,484 and the highest revenue forecast at $2,957,244,900.